145 related articles for article (PubMed ID: 36945334)
1. Apurinic/apyrimidinic endonuclease 1 is associated with poor prognosis after curative resection followed by adjuvant chemotherapy in patients with stage III colon cancer.
Song JH; Lee MS; Cha EY; Lee KH; Kim JY; Kim JS
Korean J Clin Oncol; 2022 Jun; 18(1):1-10. PubMed ID: 36945334
[TBL] [Abstract][Full Text] [Related]
2. APE1 overexpression is associated with cisplatin resistance in non-small cell lung cancer and targeted inhibition of APE1 enhances the activity of cisplatin in A549 cells.
Wang D; Xiang DB; Yang XQ; Chen LS; Li MX; Zhong ZY; Zhang YS
Lung Cancer; 2009 Dec; 66(3):298-304. PubMed ID: 19324449
[TBL] [Abstract][Full Text] [Related]
3. Expression of Apurinic/Apyrimidinic Endonuclease 1 in Colorectal Cancer and its Relation to Tumor Progression and Prognosis.
Hong JY; Oh HH; Park SY; Park YL; Cho SB; Joo YE
In Vivo; 2023; 37(5):2070-2077. PubMed ID: 37652525
[TBL] [Abstract][Full Text] [Related]
4. Human apurinic/apyrimidinic endonuclease siRNA inhibits the angiogenesis induced by X-ray irradiation in lung cancer cells.
Gu X; Cun Y; Li M; Qing Y; Jin F; Zhong Z; Dai N; Qian C; Sui J; Wang D
Int J Med Sci; 2013; 10(7):870-82. PubMed ID: 23781133
[TBL] [Abstract][Full Text] [Related]
5. Alterations in the expression of the apurinic/apyrimidinic endonuclease-1/redox factor-1 (APE1/Ref-1) in human ovarian cancer and indentification of the therapeutic potential of APE1/Ref-1 inhibitor.
Zhang Y; Wang J; Xiang D; Wang D; Xin X
Int J Oncol; 2009 Nov; 35(5):1069-79. PubMed ID: 19787261
[TBL] [Abstract][Full Text] [Related]
6. Impact of apurinic/apyrimidinic endonuclease 1/redox factor-1 on treatment response and survival in oral squamous cell carcinoma.
Hsia KT; Liu CJ; Mar K; Lin LH; Lin CS; Cheng MF; Lee HS; Chiu SY
Head Neck; 2016 Apr; 38(4):550-9. PubMed ID: 25482590
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of human apurinic/apyrimidinic endonuclease 1 (APE1) expression in breast cancer.
Woo J; Park H; Sung SH; Moon BI; Suh H; Lim W
PLoS One; 2014; 9(6):e99528. PubMed ID: 24914806
[TBL] [Abstract][Full Text] [Related]
8. Chimeric adenoviral vector Ad5/F35-mediated APE1 siRNA enhances sensitivity of human colorectal cancer cells to radiotherapy in vitro and in vivo.
Xiang DB; Chen ZT; Wang D; Li MX; Xie JY; Zhang YS; Qing Y; Li ZP; Xie J
Cancer Gene Ther; 2008 Oct; 15(10):625-35. PubMed ID: 18535621
[TBL] [Abstract][Full Text] [Related]
9. Apurinic/apyrimidinic endonuclease 1 regulates angiogenesis in a transforming growth factor β-dependent manner in human osteosarcoma.
Jiang X; Shan J; Dai N; Zhong Z; Qing Y; Yang Y; Zhang S; Li C; Sui J; Ren T; Li M; Wang D
Cancer Sci; 2015 Oct; 106(10):1394-401. PubMed ID: 26250694
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological significance of human apurinic/apyrimidinic endonuclease 1 (APE1) expression in oestrogen-receptor-positive breast cancer.
Abdel-Fatah TM; Perry C; Moseley P; Johnson K; Arora A; Chan S; Ellis IO; Madhusudan S
Breast Cancer Res Treat; 2014 Feb; 143(3):411-21. PubMed ID: 24381055
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of APE1-endonuclease activity affects cell metabolism in colon cancer cells via a p53-dependent pathway.
Codrich M; Comelli M; Malfatti MC; Mio C; Ayyildiz D; Zhang C; Kelley MR; Terrosu G; Pucillo CEM; Tell G
DNA Repair (Amst); 2019 Oct; 82():102675. PubMed ID: 31450087
[TBL] [Abstract][Full Text] [Related]
12. Human apurinic endonuclease 1 (APE1) expression and prognostic significance in osteosarcoma: enhanced sensitivity of osteosarcoma to DNA damaging agents using silencing RNA APE1 expression inhibition.
Wang D; Luo M; Kelley MR
Mol Cancer Ther; 2004 Jun; 3(6):679-86. PubMed ID: 15210853
[TBL] [Abstract][Full Text] [Related]
13. The expression of APE1 in triple-negative breast cancer and its effect on drug sensitivity of olaparib.
Chen T; Liu C; Lu H; Yin M; Shao C; Hu X; Wu J; Wang Y
Tumour Biol; 2017 Oct; 39(10):1010428317713390. PubMed ID: 29064327
[TBL] [Abstract][Full Text] [Related]
14. Role of the DNA base excision repair protein, APE1 in cisplatin, oxaliplatin, or carboplatin induced sensory neuropathy.
Kelley MR; Jiang Y; Guo C; Reed A; Meng H; Vasko MR
PLoS One; 2014; 9(9):e106485. PubMed ID: 25188410
[TBL] [Abstract][Full Text] [Related]
15. Small interfering RNA against the apurinic or apyrimidinic endonuclease enhances the sensitivity of human pancreatic cancer cells to gemcitabine in vitro.
Xiong GS; Sun HL; Wu SM; Mo JZ
J Dig Dis; 2010 Aug; 11(4):224-30. PubMed ID: 20649735
[TBL] [Abstract][Full Text] [Related]
16. Experimental study enhancing the chemosensitivity of multiple myeloma to melphalan by using a tissue-specific APE1-silencing RNA expression vector.
Yang ZZ; Chen XH; Wang D
Clin Lymphoma Myeloma; 2007 Jan; 7(4):296-304. PubMed ID: 17324338
[TBL] [Abstract][Full Text] [Related]
17. Inhibitors of nuclease and redox activity of apurinic/apyrimidinic endonuclease 1/redox effector factor 1 (APE1/Ref-1).
Laev SS; Salakhutdinov NF; Lavrik OI
Bioorg Med Chem; 2017 May; 25(9):2531-2544. PubMed ID: 28161249
[TBL] [Abstract][Full Text] [Related]
18. Dysregulation of human apurinic/apyrimidinic endonuclease 1 (APE1) expression in advanced retinoblastoma.
Sudhakar J; Khetan V; Madhusudan S; Krishnakumar S
Br J Ophthalmol; 2014 Mar; 98(3):402-7. PubMed ID: 24385289
[TBL] [Abstract][Full Text] [Related]
19. Apurinic/Apyrimidinic Endonuclease 1/Redox Factor-1 Could Serve as a Potential Serological Biomarker for the Diagnosis and Prognosis of Oral Squamous Cell Carcinoma.
Xie J; Li Y; Kong J; Li C
J Oral Maxillofac Surg; 2019 Apr; 77(4):859-866. PubMed ID: 30611690
[TBL] [Abstract][Full Text] [Related]
20. Chemical Inhibition of Apurinic-Apyrimidinic Endonuclease 1 Redox and DNA Repair Functions Affects the Inflammatory Response via Different but Overlapping Mechanisms.
Oliveira TT; Fontes-Dantas FL; de Medeiros Oliveira RK; Pinheiro DML; Coutinho LG; da Silva VL; de Souza SJ; Agnez-Lima LF
Front Cell Dev Biol; 2021; 9():731588. PubMed ID: 34616737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]